Alpha 2.0
Login Register
» Articles » PMID: 36877772

Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease

Overview
Journal Circulation
Specialty Cardiology & Vascular Diseases
Date 2023 Mar 6
PMID 36877772
Authors
Theresa J Hydes
Gregory Y H Lip
Deirdre A Lane
Affiliations
Soon will be listed here.
Citing Articles

Risk of Adverse Events in Anticoagulated Patients With Atrial Fibrillation and Nonalcoholic Fatty Liver Disease.

Bucci T, Nabrdalik K, Baratta F, Pastori D, Pignatelli P, Hydes T J Clin Endocrinol Metab. 2024; 110(1):208-217.

PMID: 38864452 PMC: 11651694. DOI: 10.1210/clinem/dgae394.

Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data.

Diesveld M, Pijnenburg D, Weersink R, Barzel I, Drenth J, Lisman T Eur J Clin Pharmacol. 2024; 80(6):797-812.

PMID: 38430266 DOI: 10.1007/s00228-024-03648-y.